NCT07025512 2026-04-16
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
Phase 2 Suspended
Clinical Trials
14 trialsNCT06886516 2026-04-15
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06521931 2026-03-02
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1 Completed
NCT07441720 2026-03-02
Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT00975819 2026-01-06
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Boston Children's Hospital
Phase 2 Completed
NCT02617745 2026-01-02
GLIOPLAK
Centre Henri Becquerel
Phase 2 Completed
NCT05255003 2025-12-17
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Ottawa Hospital Research Institute
Phase 4 Recruiting
NCT07257809 2025-12-02
Herombopag Treated T-DM1 Induced Platelet Reduction
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT04526886 2025-10-06
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT07185893 2025-09-22
A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors
Hebei Medical University Fourth Hospital
Phase NA Not yet recruiting
NCT06599762 2025-09-17
MYELO-CAN:TXA
University of Manitoba
Phase 2 Recruiting
NCT07110090 2025-09-09
Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Recruiting
NCT04861181 2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4 Terminated
NCT01660347 2025-05-02
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Thomas Jefferson University
Phase NA Withdrawn